The quality and quantity of drug safety reporting is largely insufficient, according to a recent study supported by the Agency for Healthcare Research and Quality and published in the January 24/31 Journal of the American Medical Association. The survey looked at nearly 200 drug trials and found that the severity of side effects was satisfactorily explained in less than half of them.
Jeanne Sabatie. Drug safety story not complete.
Business and Health